Overview of lamotrigine and the new antiepileptic drugs: The challenge

Journal of Child Neurology

Volumn 12, Issue SUPPL. 1, 1997, Pages

  Pellock, John M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; VALPROIC ACID;

ARTICLE; ASTHENIA; DRUG EFFICACY; EPILEPSY; FLU LIKE SYNDROME; HEADACHE; HUMAN; INSOMNIA; NAUSEA; PRIORITY JOURNAL; RASH; RHINITIS; SOMNOLENCE; TREATMENT INDICATION; VERTIGO; VOMITING;

EID: 0031422981     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073897012001111     Document Type: Article

References (19)

1. Pellock J, Watamberg N: New antiepileptic drugs in children: Present and future. Semin Pediatr Neurol 1997;4:9-18.
2. Coulter D: Antiepileptic drug cellular mechanisms of action: Where does lamotrigine fit in? J Child Neurol 1997;12(Suppl 1): S2-S9.
3. Deckers CLP, Hekster YA, Keyser A, et al: Reappraisal of polytherapy in epilepsy: A critical review of drug load and adverse effects. Epilepsia 1997;38:570-575.
4. Brodie MJ, Richens A, Yuen AWC: Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-479.
5. Yuen AWC, et al: Lamotrigine vs carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy, abstract. Epilepsia 1993;35(Suppl 5):S31-S35.
6. Steiner TJ, Silveira C, Yuen AWC, et al: Comparison of lamotrigine (Lamictal) and phenytoin monotherapy in newly diagnosed epilepsy, abstract. Epilepsia 1994;35(Suppl 7):S61.
7. Fitton A, Goa KL: Lamotrigine: An update of its pharmacology and therapeutic use in epilepsy. Drugs 1995;50(4):691-713.
8. Reunanen M, Dam M, Yuen AWC: An open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed and recurrent epilepsy. Wellcome Foundation Limited (UK), data on file, 1995.
9. Timmings PL, Richens A: Efficacy of lamotrigine as monotherapy for juvenile myoclonic epilepsy: Pilot study results. Epilepsia 1993;34(Suppl 2):S160.
10. Ayala R, Casale EJ, Brookins GA, Manasco P: The effectiveness and safety of Lamictal (lamotrigine) monotherapy for the treatment of newly diagnosed typical absence seizures in children and adolescents. Epilepsia 1996;37(Suppl 5):S165.
11. Dreifus FE: Lamotrigine in childhood epilepsies. Semin Pediatr Neurol 1997;4:19-22.
12. Shinotoh H, Vingerhoets FJG, Lee CS, et al: Lamotrigine trial in idiopathic parkinsonism: A double-blind, placebo-controlled, crossover study. Neurology 1997;48:1282-1285.
13. Uverbrant P, Bauzienè R: Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics 1994;25:284-289.
14. Donaldson JA, Glauser TA, Olberding LS: Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox-Gastaut syndrome). Epilepsia 1997;38:68-73.
15. Calabrese J: Lamotrigine in treatment of refractory bipolar disorder. Presented at American Psychiatric Association Annual Meeting, New York, NY, May 5-8, 1996.
16. Morton LD, Pellock JM: Diagnosis and treatment of epilepsy in children and adolescents. Drugs 1996;51:399-414.
17. Prescribing Information on Lamictal (Lamotrigine): Glaxo Wellcome, Inc, 1997.
18. Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-1285.
19. Trevathan E, Motte J, Arvidsson J, et al: Safety and tolerability of adjunctive Lamictal for the treatment of the Lennox-Gastaut syndrome; results of a multinational, double-blind, placebo-controlled trial, abstract. Epilepsia 1996;37(Suppl 5):S202.